DE60032254D1 - Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren - Google Patents

Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren

Info

Publication number
DE60032254D1
DE60032254D1 DE60032254T DE60032254T DE60032254D1 DE 60032254 D1 DE60032254 D1 DE 60032254D1 DE 60032254 T DE60032254 T DE 60032254T DE 60032254 T DE60032254 T DE 60032254T DE 60032254 D1 DE60032254 D1 DE 60032254D1
Authority
DE
Germany
Prior art keywords
indolderivate
hydroxyfunctional
amid
active
spla2 inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032254T
Other languages
English (en)
Inventor
Waltz Harper
Ho-Shen Lin
Enrico Richett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE60032254D1 publication Critical patent/DE60032254D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DE60032254T 1999-09-20 2000-09-07 Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren Expired - Lifetime DE60032254D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15483699P 1999-09-20 1999-09-20
PCT/US2000/020816 WO2001021587A2 (en) 1999-09-20 2000-09-07 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors

Publications (1)

Publication Number Publication Date
DE60032254D1 true DE60032254D1 (de) 2007-01-18

Family

ID=22553008

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032254T Expired - Lifetime DE60032254D1 (de) 1999-09-20 2000-09-07 Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren

Country Status (6)

Country Link
EP (1) EP1220839B1 (de)
JP (1) JP2003509491A (de)
AT (1) ATE347545T1 (de)
AU (1) AU7053700A (de)
DE (1) DE60032254D1 (de)
WO (1) WO2001021587A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002050028A2 (en) * 2000-12-18 2002-06-27 Eli Lilly And Company Substituted benzoindoles as spla2 inhibitors
EP1395554B1 (de) 2001-03-28 2007-02-14 Eli Lilly And Company Substituierte carbazole als inhibitoren von spla2
EP1960356A2 (de) 2005-11-03 2008-08-27 Ilypsa, Inc. Mehrwertige indolverbindungen und deren verwendung als phospholipase-a2-inhibitoren
WO2007056275A2 (en) * 2005-11-03 2007-05-18 Ilypsa, Inc. Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
CO4370099A1 (es) * 1994-04-01 1996-10-07 Lilly Co Eli 1H-INDOL-3-GLIOXILAMIDAS INHIBIDORAS DE sPLA2
JP2001520998A (ja) * 1997-10-27 2001-11-06 イーライ・リリー・アンド・カンパニー インドールｓＰＬＡ２阻害剤のモルホリノ−Ｎ−エチルエステルプロドラッグ
CA2309135A1 (en) * 1997-10-27 1999-05-06 Michael Lyle Denney N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors

Also Published As

Publication number Publication date
EP1220839A2 (de) 2002-07-10
ATE347545T1 (de) 2006-12-15
EP1220839B1 (de) 2006-12-06
WO2001021587A2 (en) 2001-03-29
AU7053700A (en) 2001-04-24
JP2003509491A (ja) 2003-03-11
WO2001021587A3 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
ATE540923T1 (de) Ää3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- (phenylmethyl)-11h-indol-4-ylüoxyüessigsäure methyl ester als spla2 inhibitor
DE69724009D1 (de) PYRROLE ALS sPLA2 INHIBITOREN
DE69531864D1 (de) Indolizin spal2 inhibitoren
ATE326963T1 (de) Indolverbindungen als spla2 inhibitoren
DE69720034D1 (de) PHENYLGLYOXAMIDE ALS sPLA2-INHIBITOREN
ATE350367T1 (de) Spla2 inhibitoren
ATE312817T1 (de) Cyclohept'bö indolderivate als spla2-inhibitoren
DE60032254D1 (de) Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren
WO2002012249A3 (en) Substituted pyrrole compounds and their use as spla2 inhibitors
DE60126831D1 (de) Benz(g)indole und deren verwendung als spla2 inhibitoren
WO2002050028A3 (en) Substituted benzoindoles as spla2 inhibitors
WO2001049662A3 (en) Carbazole derivatives as inhibitors of spla2
DE60120758D1 (de) Tetracyclische derivate als spla2 inhibitoren
WO2002000641A3 (en) Spla2 inhibitors

Legal Events

Date Code Title Description
8332 No legal effect for de